ID
32087
Descripción
Study ID: 103992 Clinical Study ID: 103992 Study Title: Evaluate immunogenicity, reactogenicity & safety of 2 doses of GSK Biologicals’ oral live attenuated HRV vaccine (RIX4414 at 106.5 CCID50) when given concomitantly with OPV versus given alone (HRV vaccine dose given 15 days after the OPV dose) in healthy infants in Bangladesh Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00139334 https://clinicaltrials.gov/ct2/show/NCT00139334 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis This form is for documentation of non-serious adverse events occuring during the study, excluding solicited adverse events (to be documented in the "unsolicited and solicited adverse events" form at visits 3 and 5).
Link
https://clinicaltrials.gov/ct2/show/NCT00139334
Palabras clave
Versiones (1)
- 17/10/18 17/10/18 - Sarah Riepenhausen
Titular de derechos de autor
GlaxoSmithKline
Subido en
17 de octubre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
GSK Biologicals' oral HRV vaccine given with OPV in infants NCT00139334
Non-Serious Adverse Events
- StudyEvent: ODM
Descripción
Non-Serious adverse Events
Alias
- UMLS CUI-1
- C1518404
Descripción
(Please report all serious adverse events only on the Serious Adverse Event (SAE) form). If yes, please complete the following itemgroup
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1518404
Descripción
Characteristics of non-serious adverse events
Alias
- UMLS CUI-1
- C1518404
- UMLS CUI-2
- C2348235
Descripción
AE number
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0237753
Descripción
Description
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0678257
- UMLS CUI [1,2]
- C1518404
Descripción
Date started
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0808070
Descripción
Start immediately post vaccination
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0042196
- UMLS CUI [1,2]
- C0687676
- UMLS CUI [1,3]
- C1301880
- UMLS CUI [1,4]
- C1518404
Descripción
Date stopped
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0806020
Descripción
Intensity
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0518690
- UMLS CUI [1,2]
- C1518404
Descripción
Relationship to investigational products
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0013230
- UMLS CUI [1,3]
- C0439849
Descripción
Outcome
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1705586
Descripción
For GSK
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0008961
- UMLS CUI [1,2]
- C0947611
Similar models
Non-Serious Adverse Events
- StudyEvent: ODM
C2348235 (UMLS CUI-2)
C0237753 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,4])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0947611 (UMLS CUI [1,2])